Antonio Di Stasi

5.4k total citations · 1 hit paper
42 papers, 2.8k citations indexed

About

Antonio Di Stasi is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Antonio Di Stasi has authored 42 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 22 papers in Hematology and 13 papers in Molecular Biology. Recurrent topics in Antonio Di Stasi's work include CAR-T cell therapy research (18 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Acute Myeloid Leukemia Research (12 papers). Antonio Di Stasi is often cited by papers focused on CAR-T cell therapy research (18 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Acute Myeloid Leukemia Research (12 papers). Antonio Di Stasi collaborates with scholars based in United States, Italy and South Africa. Antonio Di Stasi's co-authors include Malcolm K. Brenner, Barbara Savoldo, Helen E. Heslop, Cliona M. Rooney, Gianpietro Dotti, David M. Spencer, April Durett, Bambi Grilley, Robert A. Krance and Caridad Martinez and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Antonio Di Stasi

41 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

2011 1.2k citations Antonio Di Stasi, Siok‐Keen Tey et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Di Stasi United States	16	2.2k	954	916	887	648	42	2.8k
Catherine Lindgren United States	19	2.5k 1.2×	1.1k 1.1×	801 0.9×	691 0.8×	643 1.0×	40	2.9k
Barbara Camisa Italy	13	1.8k 0.8×	1.2k 1.2×	533 0.6×	598 0.7×	518 0.8×	27	2.6k
D. Stroncek United States	5	2.1k 1.0×	665 0.7×	652 0.7×	580 0.7×	556 0.9×	12	2.3k
Nicholas Tschernia United States	7	2.1k 1.0×	614 0.6×	656 0.7×	590 0.7×	558 0.9×	20	2.3k
Chihaya Imai Japan	17	2.1k 1.0×	1.6k 1.7×	515 0.6×	578 0.7×	409 0.6×	69	2.8k
Cindy Delbrook United States	16	2.9k 1.3×	792 0.8×	880 1.0×	760 0.9×	715 1.1×	27	3.3k
Maksim Mamonkin United States	19	1.8k 0.8×	746 0.8×	691 0.8×	738 0.8×	377 0.6×	59	2.1k
Bianca Santomasso United States	19	3.2k 1.5×	764 0.8×	683 0.7×	779 0.9×	653 1.0×	46	3.7k
Jorge Mansilla‐Soto United States	17	2.1k 1.0×	1.0k 1.1×	873 1.0×	1.6k 1.8×	695 1.1×	33	3.4k

Countries citing papers authored by Antonio Di Stasi

Since Specialization

Citations

This map shows the geographic impact of Antonio Di Stasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Di Stasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Di Stasi more than expected).

Fields of papers citing papers by Antonio Di Stasi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Di Stasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Di Stasi. The network helps show where Antonio Di Stasi may publish in the future.

Co-authorship network of co-authors of Antonio Di Stasi

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Di Stasi. A scholar is included among the top collaborators of Antonio Di Stasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Di Stasi. Antonio Di Stasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salzman, Donna, et al.. (2024). Low‐dose decitabine plus venetoclax as post‐transplant maintenance for high‐risk myeloid malignancies. SHILAP Revista de lepidopterología. 5(3). 560–564. 1 indexed citations

Noubouossie, Denis F., et al.. (2022). Passenger Lymphocyte Syndrome and Autoimmune Hypothyroidism Following Hematopoietic Stem Cell Transplantation. SHILAP Revista de lepidopterología. 2022. 1–6.

Arora, Sankalp, Kimo Bachiashvili, Ravi Bhatia, et al.. (2022). Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia. Leukemia Research. 117. 106844–106844. 10 indexed citations

Jamy, Omer, et al.. (2019). Observation Versus Immediate Reinduction for Acute Myeloid Leukemia Patients With Indeterminate Day 14 Bone Marrow Results. Clinical Lymphoma Myeloma & Leukemia. 20(1). 31–38. 4 indexed citations

Saad, Ayman, Antonio Di Stasi, Luciano J. Costa, et al.. (2018). Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant. Bone Marrow Transplantation. 53(10). 1345–1348. 3 indexed citations

Alatrash, Gheath, Peter F. Thall, Antonio Di Stasi, et al.. (2018). Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS. Bone Marrow Transplantation. 54(8). 1245–1253. 10 indexed citations

Minagawa, Kentaro & Antonio Di Stasi. (2016). Novel toxicology challenges in the era of chimeric antigen receptor T-cells therapies. Translational Cancer Research. 5(S3). S444–S449. 1 indexed citations

Minagawa, Kentaro, Mustafa Al‐Obaidi, Larisa Pereboeva, et al.. (2016). In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia. PLoS ONE. 11(12). e0166891–e0166891. 70 indexed citations

Zhou, Xiaoou, Gianpietro Dotti, Robert A. Krance, et al.. (2015). Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation. Blood. 125(26). 4103–4113. 169 indexed citations

10.

Stasi, Antonio Di, Antonio Jiménez, Kentaro Minagawa, Mustafa Al‐Obaidi, & Katayoun Rezvani. (2015). Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies. Frontiers in Immunology. 6. 36–36. 83 indexed citations

11.

Minagawa, Kentaro, Xiaoou Zhou, Shin Mineishi, & Antonio Di Stasi. (2015). Seatbelts in CAR therapy: How Safe Are CARS?. Pharmaceuticals. 8(2). 230–249. 34 indexed citations

12.

Zhou, Xiaoou, Antonio Di Stasi, & Malcolm K. Brenner. (2015). iCaspase 9 Suicide Gene System. Methods in molecular biology. 1317. 87–105. 21 indexed citations

13.

Mehta, Rohtesh S., Antonio Di Stasi, Chitra Hosing, et al.. (2014). Lenalidomide-Induced Graft-Vs.-Leukemia Effect in a Patient With Chronic Lymphocytic Leukemia Who Relapsed After Allogeneic Stem Cell Transplant. Clinical Lymphoma Myeloma & Leukemia. 14(3). e105–e109. 2 indexed citations

14.

Zhou, Xiaoou, Antonio Di Stasi, Siok‐Keen Tey, et al.. (2014). Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene. Blood. 123(25). 3895–3905. 139 indexed citations

15.

Jones, Benjamin, Lawrence S. Lamb, Frederick D. Goldman, & Antonio Di Stasi. (2014). Improving the safety of cell therapy products by suicide gene transfer. Frontiers in Pharmacology. 5. 254–254. 179 indexed citations

16.

Poon, Limei, Antonio Di Stasi, Uday Popat, Richard E. Champlin, & Stefan O. Ciurea. (2013). Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation.. PubMed. 3(3). 260–4. 29 indexed citations

17.

Stasi, Antonio Di, Amir Hamdi, Hila Shaim, et al.. (2013). Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation. Biology of Blood and Marrow Transplantation. 19(2). S286–S286. 1 indexed citations

18.

Stasi, Antonio Di, Siok‐Keen Tey, Gianpietro Dotti, et al.. (2011). Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy. New England Journal of Medicine. 365(18). 1673–1683. 1159 indexed citations breakdown →

19.

Stasi, Antonio Di, Biagio De Angelis, & Barbara Savoldo. (2010). Gene Therapy to Improve Migration of T Cells to the Tumor Site. Methods in molecular biology. 651. 103–118. 5 indexed citations

20.

Viviani, Simonetta, Massimo Di Nicola, V. Bonfante, et al.. (2010). Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience. Leukemia & lymphoma. 51(7). 1251–1259. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact